| Table 1: | |||||||||||||||||||||||||||||||||||||
|
Treatments
for Psoriasis
|
|||||||||||||||||||||||||||||||||||||
|
Level
1:
Topical Therapies |
Level
2: Phototherapies
|
Level
3:
Systemic Therapies (High Efficacy, High Toxicity) |
Level
4:
Systemic Therapy (Moderate Efficacy, Low to Moderate Toxicity)* |
Level
5:
Innovative Systemic Therapy (Moderate Efficacy, High Toxicity)* |
Level
6:
Biologic Immunomodulator Systemic Therapy |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
| *Not approved for psoriasis treatment by the US Food and Drug Administration | |||||||||||||||||||||||||||||||||||||
|
Copyright
2004 The Cleveland Clinic Foundation
|